Suppr超能文献

与非手术治疗相比,手术治疗可降低 1 年死亡率和失败率:一项倾向匹配分析。

Surgery for Vertebral Osteomyelitis Lowers 1-Year Mortality and Failure Rates Compared with Nonsurgical Treatment: A Propensity-Matched Analysis.

机构信息

Department of Orthopedics and Trauma Surgery, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.

Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.

出版信息

J Bone Joint Surg Am. 2024 Apr 3;106(7):575-581. doi: 10.2106/JBJS.23.00283. Epub 2023 Dec 29.

Abstract

BACKGROUND

The aim of this study was to determine differences between patients who underwent surgical treatment and those who underwent nonsurgical treatment of vertebral osteomyelitis (VO) and to identify potential factors influencing treatment failure (death and/or recurrence within 1 year).

METHODS

We performed a retrospective analysis of clinical data prospectively collected from patients treated for VO between 2008 and 2020. The decision between surgical and nonsurgical treatment was made for each patient based on defined criteria. A 1:1 propensity score matching was performed to exclude confounders between the 2 treatments. Univariate and multivariable analyses were performed to identify potential risk factors for death and/or recurrence within the first year after VO diagnosis.

RESULTS

Forty-two patients (11.8%) were treated nonsurgically and 313 patients (88.2%) underwent surgery. A higher percentage of the surgically treated patients than the nonsurgically treated patients had an American Society of Anesthesiologists score of >2 (69.0% versus 47.5%; p = 0.007), and the thoracic spine was affected more often in the surgical group (30.4% versus 11.9%; p = 0.013). Endocarditis was detected significantly more often in the nonsurgically treated patients (14.3% versus 4.2%; p = 0.018). The recurrence rate was 3 times higher in the nonsurgically treated patients (16.7% versus 5.4%; p = 0.017), but this difference was no longer detectable after propensity matching. After matching, the nonsurgically treated patients showed an almost 7-fold higher 1-year mortality rate (25.0% versus 3.7%; p = 0.018) and an almost 3-fold higher rate of treatment failure (42.9% versus 14.8%; p = 0.022). Multivariable analysis revealed nonsurgical treatment and bacteremia to be independent risk factors for treatment failure.

CONCLUSIONS

In our matched cohort of patients with VO, surgical intervention resulted in a significantly lower rate of treatment failure (death and/or recurrence within 1 year) compared with nonsurgical intervention. Furthermore, nonsurgical treatment was an independent risk factor for treatment failure.

LEVEL OF EVIDENCE

Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

摘要

背景

本研究旨在确定接受手术治疗和非手术治疗的椎体骨髓炎(VO)患者之间的差异,并确定影响治疗失败(1 年内死亡和/或复发)的潜在因素。

方法

我们对 2008 年至 2020 年期间接受 VO 治疗的患者的临床数据进行了回顾性分析。根据既定标准,为每位患者决定手术治疗和非手术治疗。采用 1:1 倾向评分匹配排除两种治疗方法之间的混杂因素。进行单变量和多变量分析以确定 VO 诊断后 1 年内死亡和/或复发的潜在危险因素。

结果

42 例(11.8%)患者接受非手术治疗,313 例(88.2%)患者接受手术治疗。与非手术治疗患者相比,手术治疗患者中美国麻醉医师协会评分>2 的比例更高(69.0% vs. 47.5%;p=0.007),且手术组中胸段脊柱受累更为常见(30.4% vs. 11.9%;p=0.013)。非手术治疗患者中更常发现心内膜炎(14.3% vs. 4.2%;p=0.018)。非手术治疗患者的复发率高 3 倍(16.7% vs. 5.4%;p=0.017),但在倾向匹配后,这种差异不再明显。匹配后,非手术治疗患者的 1 年死亡率高近 7 倍(25.0% vs. 3.7%;p=0.018),治疗失败率高近 3 倍(42.9% vs. 14.8%;p=0.022)。多变量分析显示,非手术治疗和菌血症是治疗失败的独立危险因素。

结论

在我们匹配的 VO 患者队列中,与非手术干预相比,手术干预可显著降低治疗失败率(1 年内死亡和/或复发)。此外,非手术治疗是治疗失败的独立危险因素。

证据水平

治疗性 III 级。有关证据水平的完整说明,请参见作者说明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验